PHI1.DEPHI1.DEXETRA
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
5Y CAGR+3.0%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

5Y CAGR
+3.0%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM15.17%+47.9%
202410.26%+79.1%
20235.73%+464.8%
2022-1.57%-115.6%
202110.10%-22.8%
202013.08%-5.3%
201913.81%-5.2%
201814.57%-0.6%
201714.66%+45.3%
201610.09%-